Sionna Therapeutics Reports Results for Quarter Ended June 30, 2026

What Happened
Sionna Therapeutics, Inc. (SION) issued a press release on August 6, 2026 announcing its financial results and business highlights for the quarter ended June 30, 2026. The 8‑K furnished the full text of that press release as Exhibit 99.1 and flagged the report under Item 2.02 (Results of Operations and Financial Condition).

Key Details

• Filing date: August 6, 2026 (Current Report on Form 8‑K).
• Reporting period: quarter ended June 30, 2026.
• Item reported: 2.02 — Results of Operations and Financial Condition (press release furnished as Exhibit 99.1).
• Technical exhibit: Interactive XBRL cover page included (Exhibit 104).

Why It Matters
The company has released its quarterly earnings and business update; investors should review the press release (Exhibit 99.1) for the specific financial figures—such as revenue, R&D and SG&A expenses, net loss or income, and cash runway—that drive valuation and near‑term outlook. This 8‑K is a formal disclosure that may contain material quarterly results and operational milestones relevant to investment decisions.